Skip to Content

IRMA (BCR-ABL KINASE DOMAIN MUTATION ANALYSIS)-NGS (SDL11709)

https://www.scanlabglobal.com/web/image/product.template/6105/image_1920?unique=18393fc
This NGS test detects BCR-ABL mutations for TKI resistance in CML. Results guide dasatinib or nilotinib therapy, overcoming imatinib resistance.

3,330.00 AED 3330.0 AED 3,330.00 AED

3,330.00 AED

Not Available For Sale

This combination does not exist.